MannKind Corporation

MannKind Corporation is a biopharmaceutical company dedicated to developing and commercializing innovative therapeutic products and devices for people living with endocrine and orphan lung diseases. They focus on creating cutting-edge technologies for drug delivery through their expertise in dry-powder formulation technology and device engineering. This allows them to address unmet medical needs by expanding routes of administration and improving patient outcomes. They are driven by a commitment to helping individuals manage serious medical conditions so they can experience the very best that life has to offer.

MannKind is known for their signature Technosphere and h-Patch technologies. Technosphere is a state-of-the-art dry powder formulation technology that optimizes drug delivery through inhalation devices, leading to improved patient outcomes. The h-Patch platform, on which their V-Go wearable insulin delivery device is built, provides a continuous, preset, subcutaneous rate of medication, eliminating the need for injections. Through partnerships with pharmaceutical organizations of all sizes, MannKind brings their innovative technologies to the market, aiming to create a world where people can live life "more humann".

MannKind Corporation offers employees a variety of work-life flexibility benefits, including a flexible work schedule, paid parental leave, and an employee assistance program. These benefits are designed to help employees balance their work and personal lives.

MannKind Corporation offers a competitive salary and a comprehensive benefits package, which includes a retirement savings program, an employee stock purchase program, healthcare benefits, work-life flexibility, holiday and PTO schedule, paid parental leave, employee recognition programs, employee assistance program, survivor benefits, and voluntary supplemental coverages such as income protection, pre-paid legal, employee referral bonus, pet insurance, and identify theft protection. Additionally, all employees are eligible for a bonus plan and an annual equity program.

MannKind Corporation is a biopharmaceutical company dedicated to developing and commercializing innovative therapeutic products and devices for people living with endocrine and orphan lung diseases. They strive to create cutting-edge therapies and technologies that can help people manage serious medical conditions so they can experience the best of what life has to offer. Their approach is driven by solutions-based scientists and medical professionals committed to helping people live life "more humann".

MannKind promotes a culture of innovation and collaboration, fueled by a strong entrepreneurial spirit. They value diversity and respect, encouraging employees to push boundaries, think creatively, and work together to achieve their goals. This environment fosters a sense of ownership and tenacity, emphasizing a commitment to making a real difference in the lives of patients.

MannKind Corporation emphasizes the importance of diversity, equity, and inclusion in its clinical trials and workplace. They believe in embracing individuals from diverse backgrounds, ethnicities, ages, and genders to ensure their research reflects the full gamut of people who will benefit from their medical products. They are committed to creating a work environment where diversity of background, thought, and perspective is valued and respected.